Activation of ROS/MAPK s /NF‐ κ B/NLRP3 and inhibition of efferocytosis in osteoclast‐mediated diabetic osteoporosis-Reference-Cited by-同舟云学术

Activation of ROS/MAPK s /NF‐ κ B/NLRP3 and inhibition of efferocytosis in osteoclast‐mediated diabetic osteoporosis

Published:2019-08-28 Issue:11 Volume:33 Page:12515-12527
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

An Yanan¹,Zhang Haifeng¹,Wang Chao¹,Jiao Fangtai¹,Xu Hongyue¹,Wang Xuefei¹,Luan Wenjing¹,Ma Fangxue¹,Ni Lihui¹,Tang Xudong²,Liu Mingyuan²³,Guo Weiying¹,Yu Lu¹

Affiliation:

1. Department of Endocrinology, Department of Interventional TherapyFirst Hospital of Jilin University, Key Laboratory of Zoonosis Research, Ministry of Education, and Institute of Zoonosis, College of Veterinary Medicine, Jilin UniversityChangchunChina

2. Key Laboratory for New Drugs Research of Traditional Chinese Medicine (TCM), Research Institute of Tsinghua University in ShenzhenShenzhenChina

3. Jiangsu Coinnovation Center for Prevention and Control of Important Animal Infectious Diseases and ZoonosisYangzhouChina

Funder

Education Department of Jilin Province

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201802805RR

Reference53 articles.

1. Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats